Girum D Hailedingle, MD | |
110 Irving St Nw, Washington, DC 20010-2976 | |
(301) 946-5100 | |
(301) 929-0348 |
Full Name | Girum D Hailedingle |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 31 Years |
Location | 110 Irving St Nw, Washington, District Of Columbia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538243712 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | MD035010 (District Of Columbia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Howard University Hospital | Washington, DC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Us Anesthesia Partners Of Dc Pc | 7719395888 | 18 |
News Archive
A team of scientists from Israel has recently claimed that antiviral immunity induced by the mRNA-based coronavirus disease 2019 (COVID-19) BNT162b2 gradually declines over time, highlighting the need for a third booster dose.
William M. Tierney, M.D., president and CEO of the Regenstrief Institute and associate dean for clinical effectiveness research at the Indiana University School of Medicine, received a 2011 Distinguished Investigator Award presented at the Clinical and Translational Research and Education Meeting on April 28 in Washington, DC.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
Zeus Industrial Products, Inc., the global leader in advanced polymer solutions, announced today that it has finalized an agreement to integrate CathX Medical Inc. into its organization.
› Verified 6 days ago
Entity Name | Howard University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033163597 PECOS PAC ID: 0941109565 Enrollment ID: O20040102000561 |
News Archive
A team of scientists from Israel has recently claimed that antiviral immunity induced by the mRNA-based coronavirus disease 2019 (COVID-19) BNT162b2 gradually declines over time, highlighting the need for a third booster dose.
William M. Tierney, M.D., president and CEO of the Regenstrief Institute and associate dean for clinical effectiveness research at the Indiana University School of Medicine, received a 2011 Distinguished Investigator Award presented at the Clinical and Translational Research and Education Meeting on April 28 in Washington, DC.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
Zeus Industrial Products, Inc., the global leader in advanced polymer solutions, announced today that it has finalized an agreement to integrate CathX Medical Inc. into its organization.
› Verified 6 days ago
Entity Name | Medstar Medical Group Anesthesiology Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528578333 PECOS PAC ID: 1052678034 Enrollment ID: O20171129001837 |
News Archive
A team of scientists from Israel has recently claimed that antiviral immunity induced by the mRNA-based coronavirus disease 2019 (COVID-19) BNT162b2 gradually declines over time, highlighting the need for a third booster dose.
William M. Tierney, M.D., president and CEO of the Regenstrief Institute and associate dean for clinical effectiveness research at the Indiana University School of Medicine, received a 2011 Distinguished Investigator Award presented at the Clinical and Translational Research and Education Meeting on April 28 in Washington, DC.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
Zeus Industrial Products, Inc., the global leader in advanced polymer solutions, announced today that it has finalized an agreement to integrate CathX Medical Inc. into its organization.
› Verified 6 days ago
Entity Name | Us Anesthesia Partners Of Dc Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710598859 PECOS PAC ID: 7719395888 Enrollment ID: O20210412000137 |
News Archive
A team of scientists from Israel has recently claimed that antiviral immunity induced by the mRNA-based coronavirus disease 2019 (COVID-19) BNT162b2 gradually declines over time, highlighting the need for a third booster dose.
William M. Tierney, M.D., president and CEO of the Regenstrief Institute and associate dean for clinical effectiveness research at the Indiana University School of Medicine, received a 2011 Distinguished Investigator Award presented at the Clinical and Translational Research and Education Meeting on April 28 in Washington, DC.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
Zeus Industrial Products, Inc., the global leader in advanced polymer solutions, announced today that it has finalized an agreement to integrate CathX Medical Inc. into its organization.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Girum D Hailedingle, MD 11510 Georgia Ave, Suite 206, Wheaton, MD 20902-1925 Ph: (301) 946-5100 | Girum D Hailedingle, MD 110 Irving St Nw, Washington, DC 20010-2976 Ph: (301) 946-5100 |
News Archive
A team of scientists from Israel has recently claimed that antiviral immunity induced by the mRNA-based coronavirus disease 2019 (COVID-19) BNT162b2 gradually declines over time, highlighting the need for a third booster dose.
William M. Tierney, M.D., president and CEO of the Regenstrief Institute and associate dean for clinical effectiveness research at the Indiana University School of Medicine, received a 2011 Distinguished Investigator Award presented at the Clinical and Translational Research and Education Meeting on April 28 in Washington, DC.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
Zeus Industrial Products, Inc., the global leader in advanced polymer solutions, announced today that it has finalized an agreement to integrate CathX Medical Inc. into its organization.
› Verified 6 days ago
Dr. Fay Horng, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7504 | |
Dr. Matthew Mueller, DO, MPH Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Dr. Shane Zamani, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 900 23rd St Nw, Washington, DC 20037 Phone: 202-715-4750 | |
Dr. Thomas Edward Borsari, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 50 Irving St Nw, Dept Of Anesthesiology, Washington, DC 20422 Phone: 202-745-8000 | |
Alexis Lambros, CAA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-2025 | |
Susan Verghese, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-884-2025 | |
Joan Threlfall, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-8640 |